StockData
Trevi Therapeutics, Inc. logo

Trevi Therapeutics, Inc. (TRVI) stock

TRVINasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 7/30
$13.51+0.00 (0.00%)

Close on Nov 18, 2026Market cap $1.92BP/E –Yield –

Trevi Therapeutics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Trevi Therapeutics's market cap was $2.11B on Nov 11, 2026, against $1.69B a year earlier. Over the last 5 years it ranged from $11.83M to $2.39B, with a median of $213.78M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$2.11B+31.4%
2025Dec 31, 2025$1.61B+416.4%
2024Dec 31, 2024$310.87M+263.3%
2023Dec 29, 2023$85.57M-24.0%
2022Dec 30, 2022$112.56M+675.9%
2021Dec 31, 2021$14.51M-67.3%
2020Dec 31, 2020$44.34M-33.7%
2019Dec 31, 2019$66.88M–

More Trevi Therapeutics figures

See a number that looks wrong?